Lataa...
Endostatin improves cancer-associated systemic syndrome in a lung cancer model
Cancer-associated systemic syndrome (CASS) is characterized by a constellation of symptoms, including progressive weight loss, anemia, endocrine disorders, gastrointestinal dysfunction, muscle and adipose atrophy, hepatic peliosis and kidney failure. The present study assesses the effects of endosta...
Tallennettuna:
| Julkaisussa: | Oncol Lett |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4467285/ https://ncbi.nlm.nih.gov/pubmed/26137006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3049 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|